All Stories

  1. Enhanced Oral Delivery of Turmeric Extract via Spray-Dried Microparticles: Biopharmaceutical Performance and In Vitro Microbiota Modulation
  2. Data from Machine Learning Predicts Hepatocellular Carcinoma Risk from Routine Clinical Data: A Large Population-Based Multicentric Study
  3. Supplementary Figures S1 - S12 from Machine Learning Predicts Hepatocellular Carcinoma Risk from Routine Clinical Data: A Large Population-Based Multicentric Study
  4. Supplementary Tables ST1 - ST29 from Machine Learning Predicts Hepatocellular Carcinoma Risk from Routine Clinical Data: A Large Population-Based Multicentric Study
  5. Editorial: Spontaneous Bacterial Peritonitis—Redrawing Empiric Therapy in the Era of Multidrug Resistance
  6. Development of a longitudinal predictive model for hepatocellular carcinoma occurrence in patients with chronic hepatitis B
  7. Editorial: Bile Acids Under Bulevirtide: A Pharmacodynamic Signature, Not a Prognostic Biomarker
  8. Machine learning predicts hepatocellular carcinoma risk from routine clinical data: a large population-based multicentric study
  9. Impact of cardiometabolic risk factors on hepatocellular carcinoma incidence in patients with chronic hepatitis B: A retrospective cohort study
  10. Percutaneous endoscopic gastrostomy improves survival and nutritional outcomes in patients with head and neck cancer
  11. Editorial: Advancing HCC Surveillance in Hepatitis B With Biomarker‐Based Strategy—Authors' Reply
  12. Cost‐Utility Analysis of Biomarker‐Based vs. USG + AFP Strategies for HCC Surveillance in Chronic Hepatitis B
  13. Whole-Genome Sequencing and Antibiotic Resistance Profiling of Helicobacter pylori Isolates from a Tertiary Hospital in Southern Thailand
  14. A nationwide population-based cross-sectional time series study of hospitalized chronic liver disease burden in Thailand from 2017 to 2022
  15. Enhancing ultrasonographic detection of hepatocellular carcinoma with artificial intelligence: current applications, challenges and future directions
  16. Rising Incidence of Early-Onset Liver Cancer and Intrahepatic Bile Duct Cancer: Analysis of the National Childhood Cancer Registry Database
  17. Serum sodium level is predictive for kidney injury or hyponatremia after modest-volume paracentesis (<5 L) in Asian patients with cirrhosis: A single-centered retrospective observational study
  18. Coexisting steatotic liver disease is not associated with long-term liver-related events in patients with chronic hepatitis B
  19. Current and new strategies for hepatocellular carcinoma surveillance
  20. Role of Plasma Exchange and Combining Therapies in Dengue-Associated Acute Liver Failure: A Systematic Review of Individual Cases
  21. Tumor burden with AFP improves survival prediction for TACE-treated patients with HCC: An international observational study☆
  22. Asian Perspective on Hepatitis B Virus and Hepatitis C Virus Elimination
  23. Statin Use in Metabolic Dysfunction-Associated Steatotic Liver Disease and Effects on Vibration-Controlled Transient Elastography-Derived Scores—A Population-Based Inverse Probability Treatment Weighting Analysis
  24. Sequential SAFE Score and Transient Elastography for Detecting Significant Fibrosis in Asian Patients with MASLD
  25. Beyond the Liver: A Comprehensive Review of Strategies to Prevent Hepatocellular Carcinoma
  26. Characteristics and long-term mortality of individuals with MASLD, MetALD, and ALD, and the utility of SAFE score
  27. Effect of mouthwash containing poly l-Lysine and glycerol monolaurate on oral Helicobacter pylori relating to biofilm eradication, anti-adhesion, and pro-inflammatory cytokine suppression
  28. Clostridioides difficile Infection in the Elderly: Trend Analysis from 2000 to 2019
  29. Clinical Utility of the aMAP Score for Predicting Hepatocellular Carcinoma Development in Patients with Chronic Hepatitis B
  30. Efficacy of Vonoprazan vs. Intravenous Proton Pump Inhibitor in Prevention of Re-Bleeding of High-Risk Peptic Ulcers: A Randomized Controlled Pilot Study
  31. Effect of smartphone-assisted lifestyle intervention in MASLD patients: a randomized controlled trial
  32. Global epidemiology of alcohol‐associated liver disease in adolescents and young adults
  33. Liver Transplantation in Chronic Liver Disease and Acute on Chronic Liver Failure- Indication, Timing and Practices
  34. Prevalence and virulence factors of Helicobacter pylori isolated from oral cavity of non-disease, gastritis, and gastric cancer patients
  35. Non-Invasive Serum Biomarkers for the Diagnosis of Cirrhosis in Patients with Autoimmune Hepatitis (AIH) and AIH-Primary Biliary Cholangitis Overlap Syndrome (AIH-PBC): Red Cell Distribution Width to Platelet Ratio (RPR) Yielded the Most Promising Result
  36. Health-related quality of life in Thai patients with chronic hepatitis B
  37. Characterization of adhesion, anti-adhesion, co-aggregation, and hydrophobicity of Helicobacter pylori and probiotic strains
  38. Heterologous COVID-19 Vaccination and Booster with mRNA Vaccine Provide Enhanced Immune Response in Patients with Cirrhosis: A Prospective Observational Study
  39. Lower pretreatment HBV DNA levels are associated with better off-treatment outcomes after nucleo(s)tide analogue withdrawal in patients with HBeAg-negative chronic hepatitis B: A multicentre cohort study
  40. Ethnic disparities in waitlist outcomes of patients with nonalcoholic steatohepatitis listed for liver transplantation in the US
  41. HBV seroprevalence and liver fibrosis status among population born before national immunization in Southern Thailand: Findings from a health check-up program
  42. Probability of HBsAg loss after nucleo(s)tide analogue withdrawal depends on HBV genotype and viral antigen levels
  43. Massive biliary ascariasis: an unusual cause of acute cholangitis
  44. Validation of the “Six-and-Twelve” Prognostic Score in Transarterial Chemoembolization–Treated Hepatocellular Carcinoma Patients
  45. Amoxycillin-Clavulanic Acid-Induced Esophageal Ulcer: An Unusual Cause
  46. Hepatitis B surface antigen, core‐related antigen and HBV RNA: Predicting clinical relapse after NA therapy discontinuation
  47. Pre-existing liver disease is associated with poor outcome in patients with SARS CoV2 infection; The APCOLIS Study (APASL COVID-19 Liver Injury Spectrum Study)
  48. Elephantiasic Pretibial Myxedema: A Rare Manifestation in Graves’ Disease
  49. Phlegmonous Proctitis: A Rare Entity of the Presentation of Proctitis
  50. Acral Hyperpigmentation Resulting from Hydroxyurea Therapy in Primary Myelofibrosis
  51. Efficacy and safety profile of autologous blood versus talc pleurodesis for malignant pleural effusion: a randomized controlled trial
  52. Efficacy and safety profile of autologous blood Vs talc pleurodesis for MPE